A clinical approach to treating pain in chronic pancreatitis

Baharak Moshiree, Phillip P. Toskes

Research output: Contribution to journalArticle

Abstract

Objective.To discuss the clinical approach to treating pain in chronic pancreatitis (CP). Methods: Review of the literature. Results: CP is an inflammatory condition characterized by irreversible and progressive destruction of the pancreatic parenchyma and pancreatic ducts, which leads to debilitating symptoms of severe abdominal pain. The etiology of pain in pancreatitis is multifactorial. Currently, as none of the therapies can counteract the inflammatory process of CP, management has included analgesics for pain management and enzyme replacement for exocrine insufficiency, with endoscopic and surgical techniques reserved for treating the complications of CP, such as ductal anatomic abnormalities. Diagnostic techniques are now underway to improve early detection of CP for both optimizing treatments and for prevention of complications, which include malabsorption, ductal obstruction, and pancreatic cancer. Noninvasive methods for pain management such as nonenteric-coated pancreatic enzymes, prokinetics in cases of concomitant gastric dysmotility due to CP, pregabalin, antioxidants, nerve blocks, and endoscopic interventions have yielded better results than were found in the past decade. Conclusion: As the pathophysiology of CP is fully delineated, the resultant pancreatic exocrine and endocrine Insufficiencies associated with the disease can be better treated.

Original languageEnglish
Pages (from-to)77-82
Number of pages6
JournalJournal of Clinical Outcomes Management
Volume20
Issue number2
StatePublished - Feb 1 2013

Fingerprint

Chronic Pancreatitis
Pain
Pain Management
Exocrine Pancreatic Insufficiency
Nerve Block
Pancreatic Ducts
Enzymes
Pancreatic Neoplasms
Pancreatitis
Abdominal Pain
Analgesics
Stomach
Antioxidants
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

A clinical approach to treating pain in chronic pancreatitis. / Moshiree, Baharak; Toskes, Phillip P.

In: Journal of Clinical Outcomes Management, Vol. 20, No. 2, 01.02.2013, p. 77-82.

Research output: Contribution to journalArticle

Moshiree, Baharak ; Toskes, Phillip P. / A clinical approach to treating pain in chronic pancreatitis. In: Journal of Clinical Outcomes Management. 2013 ; Vol. 20, No. 2. pp. 77-82.
@article{2122a4fd835c4ce3a7a3cbc5119810e7,
title = "A clinical approach to treating pain in chronic pancreatitis",
abstract = "Objective.To discuss the clinical approach to treating pain in chronic pancreatitis (CP). Methods: Review of the literature. Results: CP is an inflammatory condition characterized by irreversible and progressive destruction of the pancreatic parenchyma and pancreatic ducts, which leads to debilitating symptoms of severe abdominal pain. The etiology of pain in pancreatitis is multifactorial. Currently, as none of the therapies can counteract the inflammatory process of CP, management has included analgesics for pain management and enzyme replacement for exocrine insufficiency, with endoscopic and surgical techniques reserved for treating the complications of CP, such as ductal anatomic abnormalities. Diagnostic techniques are now underway to improve early detection of CP for both optimizing treatments and for prevention of complications, which include malabsorption, ductal obstruction, and pancreatic cancer. Noninvasive methods for pain management such as nonenteric-coated pancreatic enzymes, prokinetics in cases of concomitant gastric dysmotility due to CP, pregabalin, antioxidants, nerve blocks, and endoscopic interventions have yielded better results than were found in the past decade. Conclusion: As the pathophysiology of CP is fully delineated, the resultant pancreatic exocrine and endocrine Insufficiencies associated with the disease can be better treated.",
author = "Baharak Moshiree and Toskes, {Phillip P.}",
year = "2013",
month = "2",
day = "1",
language = "English",
volume = "20",
pages = "77--82",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "2",

}

TY - JOUR

T1 - A clinical approach to treating pain in chronic pancreatitis

AU - Moshiree, Baharak

AU - Toskes, Phillip P.

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Objective.To discuss the clinical approach to treating pain in chronic pancreatitis (CP). Methods: Review of the literature. Results: CP is an inflammatory condition characterized by irreversible and progressive destruction of the pancreatic parenchyma and pancreatic ducts, which leads to debilitating symptoms of severe abdominal pain. The etiology of pain in pancreatitis is multifactorial. Currently, as none of the therapies can counteract the inflammatory process of CP, management has included analgesics for pain management and enzyme replacement for exocrine insufficiency, with endoscopic and surgical techniques reserved for treating the complications of CP, such as ductal anatomic abnormalities. Diagnostic techniques are now underway to improve early detection of CP for both optimizing treatments and for prevention of complications, which include malabsorption, ductal obstruction, and pancreatic cancer. Noninvasive methods for pain management such as nonenteric-coated pancreatic enzymes, prokinetics in cases of concomitant gastric dysmotility due to CP, pregabalin, antioxidants, nerve blocks, and endoscopic interventions have yielded better results than were found in the past decade. Conclusion: As the pathophysiology of CP is fully delineated, the resultant pancreatic exocrine and endocrine Insufficiencies associated with the disease can be better treated.

AB - Objective.To discuss the clinical approach to treating pain in chronic pancreatitis (CP). Methods: Review of the literature. Results: CP is an inflammatory condition characterized by irreversible and progressive destruction of the pancreatic parenchyma and pancreatic ducts, which leads to debilitating symptoms of severe abdominal pain. The etiology of pain in pancreatitis is multifactorial. Currently, as none of the therapies can counteract the inflammatory process of CP, management has included analgesics for pain management and enzyme replacement for exocrine insufficiency, with endoscopic and surgical techniques reserved for treating the complications of CP, such as ductal anatomic abnormalities. Diagnostic techniques are now underway to improve early detection of CP for both optimizing treatments and for prevention of complications, which include malabsorption, ductal obstruction, and pancreatic cancer. Noninvasive methods for pain management such as nonenteric-coated pancreatic enzymes, prokinetics in cases of concomitant gastric dysmotility due to CP, pregabalin, antioxidants, nerve blocks, and endoscopic interventions have yielded better results than were found in the past decade. Conclusion: As the pathophysiology of CP is fully delineated, the resultant pancreatic exocrine and endocrine Insufficiencies associated with the disease can be better treated.

UR - http://www.scopus.com/inward/record.url?scp=84881150599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881150599&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84881150599

VL - 20

SP - 77

EP - 82

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 2

ER -